| Serial Number | 79339085 |
| Word Mark | CR |
| Filing Date | Wednesday, February 23, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 25, 2023 |
| Registration Number | 7033274 |
| Registration Date | Tuesday, April 25, 2023 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, February 7, 2023 |
| Description of Mark | The mark consists of an abstract design consisting of circular and curved line shapes depicting the letters "CR". |
| Goods and Services | Chemical reagents for medical or veterinary purposes; disinfectants; radioactive substances for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; nutritive substances for microorganisms cultures; diagnostic preparations for medical purposes; Biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; surgical implants comprised of living tissues; veterinary preparations for the prevention and treatment of intestinal bacteria, colibacillosis, salmonellosis, pasteurella, brucellosis, foot-and-mouth disease, tuberculosis, plague, infectious diseases, influenza, immune related diseases and nutrient deficiency related diseases; preparations for destroying noxious animals |
| Goods and Services | Product quality testing services; technological research in the field of medicines and biological preparations; research and development of pharmaceuticals for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; genome structure and function analysis; genetic testing for scientific research purposes; Medical and scientific research, namely, conducting clinical trials for others; The testing of starting materials, intermediate products and end products of protein, cell and gene therapy pharmaceutical products |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 29, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, April 29, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Corregene Biotechnology Co., Ltd |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Corregene Biotechnology Co., Ltd |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Corregene Biotechnology Co., Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Friday, August 4, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, August 4, 2023 | FINAL DISPOSITION PROCESSED |
| Tuesday, July 25, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, April 25, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, April 25, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 7, 2023 | NOTIFICATION PROCESSED BY IB |
| Tuesday, February 7, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 7, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 18, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 18, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, January 18, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, January 5, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 16, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 15, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 15, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 15, 2022 | REFUSAL PROCESSED BY IB |
| Saturday, October 22, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, October 21, 2022 | REFUSAL PROCESSED BY MPU |
| Wednesday, August 31, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, August 30, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, August 25, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, May 3, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, April 29, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 28, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |